SCHEMBL4953283

SCHEMBL4953283

Oc1cc2ncn(OCc3ccccc3)c2cc1O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 3/20 0.51
SRC P12931 3/20 0.51
CYP1A2 P05177 2/20 0.39
CYP2C19 P33261 2/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
AGER Q15109 1/20 0.39
PLK1 P53350 3/20 0.38
MAOB P27338 1/20 0.38
LMNA P02545 1/20 0.37
PTGS1 P23219 1/20 0.37
SLC6A2 P23975 1/20 0.37
PTGS2 P35354 1/20 0.37
SLC6A3 Q01959 1/20 0.37
HIF1A Q16665 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37
ALPL P05186 2/20 0.36
ALPG P10696 2/20 0.36
ALPI P09923 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4953943 0.89 FGFR1 (0.40) FGFR1SRCCYP1A2CYP2C19CYP3A4
SCHEMBL4954023 0.89 FGFR1 (0.40) FGFR1SRCCYP1A2CYP2C19CYP3A4
SCHEMBL4953142 0.82 FGFR1 (0.37) FGFR1CYP1A2CYP2C19CYP3A4CYP2D6
SCHEMBL9672155 0.80 CYP11B1 (0.53) CYP1A2CYP2C19CYP3A4CYP2D6CYP2C9
SCHEMBL4956857 0.76 FGFR1 (0.42) FGFR1SRCLMNAALPGPLAA
SCHEMBL4954750 0.75 FGFR1 (0.41) FGFR1SRCPLAA
SCHEMBL4955326 0.73 SRC (0.41) SRCCYP1A2CYP2C19MAOBLMNA
SCHEMBL4952646 0.71 FGFR1 (0.46) FGFR1SRCALPGPLAATNF
SCHEMBL4952594 0.71 SRC (0.51) FGFR1SRCLMNATNFCYP11B1
SCHEMBL5440115 0.68 LTA4H (0.50) CYP1A2CYP2C19CYP3A4CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7371264-B2 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof THE PROCTER & GAMBLE COMPANY (US) 2008-05-13 US claimed
US-20060042026-A1 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof THE PROCTER & GAMBLE COMPANY (US) 2006-03-02 US claimed
US-7371264-B2 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof THE PROCTER & GAMBLE COMPANY (US) 2008-05-13 US disclosed
EP-1781379-A1 KERATIN DYEING COMPOUNDS, KERATIN DYEING COMPOSITIONS CONTAINING THEM, AND USE THEREOF The Procter and Gamble Company (US) 2007-05-09 EP disclosed
WO-2006026495-A1 KERATIN DYEING COMPOUNDS, KERATIN DYEING COMPOSITIONS CONTAINING THEM, AND USE THEREOF THE PROCTER & GAMBLE COMPANY (US) 2006-03-09 WO disclosed
US-20060042026-A1 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof THE PROCTER & GAMBLE COMPANY (US) 2006-03-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060042026-A1 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof KRT18, KDM5A, KDM5C FGFR1 3538/4885SRC 2096/4885CYP1A2 764/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.